Truist Financial Corp Sells 7,849 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Truist Financial Corp reduced its position in Henry Schein, Inc. (NASDAQ:HSIC) by 47.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,688 shares of the company’s stock after selling 7,849 shares during the quarter. Truist Financial Corp’s holdings in Henry Schein were worth $705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of HSIC. Bank Julius Baer & Co. Ltd Zurich boosted its position in shares of Henry Schein by 67,055.8% in the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 6,737,741 shares of the company’s stock worth $546,431,000 after purchasing an additional 6,727,708 shares during the period. Perpetual Ltd bought a new position in shares of Henry Schein during the first quarter worth $347,420,000. Morgan Stanley boosted its position in shares of Henry Schein by 143.4% during the fourth quarter. Morgan Stanley now owns 2,337,890 shares of the company’s stock worth $186,727,000 after acquiring an additional 1,377,207 shares during the last quarter. Norges Bank bought a new position in shares of Henry Schein during the fourth quarter worth $109,932,000. Finally, Longview Partners Guernsey LTD boosted its position in shares of Henry Schein by 3.5% during the first quarter. Longview Partners Guernsey LTD now owns 7,263,670 shares of the company’s stock worth $592,280,000 after acquiring an additional 248,659 shares during the last quarter. 93.31% of the stock is currently owned by institutional investors.

Henry Schein Trading Up 0.7 %

Shares of HSIC opened at $63.43 on Thursday. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $89.72. The company has a market cap of $8.28 billion, a P/E ratio of 18.66, a P/E/G ratio of 1.74 and a beta of 0.87. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 0.27. The company’s fifty day simple moving average is $71.35 and its 200-day simple moving average is $75.70.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, August 7th. The company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.03. Henry Schein had a net margin of 3.64% and a return on equity of 15.76%. The business had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.13 billion. During the same quarter in the prior year, the firm posted $1.16 earnings per share. The business’s revenue for the quarter was up 2.3% on a year-over-year basis. As a group, analysts expect that Henry Schein, Inc. will post 5.26 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on HSIC. Stifel Nicolaus dropped their target price on shares of Henry Schein from $80.00 to $70.00 and set a “hold” rating for the company in a research report on Wednesday, November 1st. JPMorgan Chase & Co. upped their target price on shares of Henry Schein from $80.00 to $83.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 9th. Bank of America decreased their price target on shares of Henry Schein from $76.00 to $75.00 in a research note on Monday, August 7th. Piper Sandler decreased their price target on shares of Henry Schein from $94.00 to $84.00 and set an “overweight” rating on the stock in a research note on Thursday, October 26th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and set a $96.00 price target on shares of Henry Schein in a research note on Tuesday, August 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $81.13.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.